CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Regenxbio Inc Company Snapshot
Regenxbio Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Regenxbio Inc with three other companies in this sector in the United States: Crispr Therapeutics AG (2016 sales of $5.16 million ), Cleveland Biolabs, Inc. ($3.52 million of which 100% was Biological Compound), and Clinuvel Pharmaceuticals Limited ($5.11 million of which 100% was Biotechnology).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Regenxbio Inc
  Stock Performance Chart for Regenxbio Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 27.10
(Figures in U.S. Dollars)
1 Week -11.0%   13 Weeks -19.5%  
4 Weeks -17.3%   52 Weeks 36.2%  
 
Regenxbio Inc Key Data:
  Ticker: RGNX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 4,589,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 844,037,413
  Fiscal Yr Ends: December Shares Outstanding: 31,145,292
  Share Type: Common Closely Held Shares: 5,263,271
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.